| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Metronidazole | FAERS: 9 | US FAERS | |
| 2 | Levofloxacin | FAERS: 7 | US FAERS | |
| 3 | Lisinopril | FAERS: 7 | US FAERS | |
| 4 | Simvastatin | FAERS: 6 | US FAERS | |
| 5 | Atorvastatin | FAERS: 3 | US FAERS | |
| 6 | Atorvastatin | FAERS: 2 | US FAERS | |
| 7 | Azathioprine | FAERS: 1 | US FAERS | |
| 8 | Decitabine | FAERS: 1 | US FAERS | |
| 9 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Leflunomide | FAERS: 1 | US FAERS | |
| 11 | PCI 32765 | FAERS: 1 | US FAERS | |
| 12 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 13 | Tazobactam | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.